AMETEK (AME) Following Raised Earnings Views, Is The Bull Case Now In The Price?
Analysts have recently raised earnings expectations for AMETEK (AME) ahead of its upcoming quarterly report, with projections pointing to $1.99 in EPS and $1.96b in revenue, both higher than the prior year period.
See our latest analysis for AMETEK.
AMETEK’s share price has risen 15.57% year to date and its 1 year total shareholder return is 33.38%, which suggests recent optimism around earnings is building on already solid long term performance.
If you are looking beyond AMETEK for other potential ideas in industrial technology and automation, this could be a good moment to check out 35 robotics and automation stocks
After a 15.57% year to date move and a consensus target sitting above the current price, the spread in AMETEK’s valuation signals a clear tension. Do recent gains already capture fair value, or is there still room for further adjustment?
Most Popular Narrative: 7% Undervalued
The most followed narrative currently pegs AMETEK’s fair value at $259.05, slightly above the last close at $241.71, which frames the current debate around upside.
Adoption of digital reality, automation, and advanced metrology solutions is accelerating across key end markets such as aerospace, defense, and architecture, recently reinforced by the FARO Technologies acquisition, which expands AMETEK's addressable market and supports both revenue and margin growth through higher value, software enabled recurring revenue streams.
Want to see what earnings, margins and revenue mix need to look like for that fair value to stack up? The narrative focuses on steady compounding, a richer profit profile and a premium future multiple tied to this automation push. Curious which assumptions really carry the valuation story?
Result: Fair Value of $259.05 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, AMETEK’s story can shift quickly if acquisition execution disappoints, or if prolonged softness in semiconductor and research demand weighs more heavily on its growth profile.
Find out about the key risks to this AMETEK narrative.
Another View On AMETEK’s Valuation
The most popular AMETEK narrative leans on a fair value of $259.05, which implies some upside from the recent $241.71 share price. Our DCF model paints a very different picture, with an estimate of future cash flow value at $176.38, which points to AMETEK trading above this level. Which framework do you trust more when the signals clash?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out AMETEK for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 55 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Mixed signals around AMETEK can make the story feel unclear, so this is a good time to review the numbers yourself and decide what they really imply. To see what the market is currently optimistic about, start with the 3 key rewards.
Looking for more investment ideas beyond AMETEK?
If AMETEK has sharpened your focus on quality, consider using this moment to widen your opportunity set with other stocks that could fit your goals.
- Broaden your hunt for potential bargains by scanning companies that screen as attractively priced on fundamentals using the 55 high quality undervalued stocks.
- Prioritise strength and resilience by filtering for companies with robust finances through the solid balance sheet and fundamentals stocks screener (45 results).
- Unearth lesser known opportunities before the crowd by reviewing the screener containing 19 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com